All of medical evidence,
distilled into one answer
Clinical answers you can trust — cited, graded, and aware of the patient.
Vero searches trusted medical sources and grades what it finds.
Evidence, in focus.
Worth starting an SGLT2 inhibitor for CKD without diabetes?
Yes — SGLT2 inhibitors slow eGFR decline and cut kidney-failure risk in proteinuric CKD, with or without diabetes.pubmedL1
Guidelines now recommend them alongside ACE inhibition down to an eGFR of 20.nice
Expect a small initial eGFR dip; recheck in two to four weeks.cmajL2
Empagliflozin in patients with chronic kidney disease
Randomized controlled trial · 6,609 patients
Answers with receipts
Vero searches the medical literature, not the open web, and shows you exactly where every answer comes from.
Trusted sources only. Journals, guideline bodies, and public-health agencies — never forums or blogs.
Graded where it counts. Trial literature carries a level-of-evidence badge from L1 to L4.
One tap to the paper. Every citation links out, so you can read the study behind the sentence.
Anticoagulate after AF ablation?
Oral anticoagulation after catheter ablation for atrial fibrillation
Atrial fibrillation: diagnosis and management
Stroke risk after ablation in patients who stop anticoagulants
Systematic reviews & RCTs
The strongest trial evidence
Cohort studies
Groups followed over time
Case-control & series
Observational comparisons
Expert opinion
Consensus and mechanism
Start in the literature
Evidence mode opens Vero Chat with the literature front and center — suggested starting points for the questions clinic days actually raise.
Five ways in. Reference, assessment, medication, patient, and panel prompts to start from.
Still your chat. Notes, tasks, and patient context stay one message away — evidence mode never walls them off.
What should we look up?
Evidence mode · cited answers
Max metformin at eGFR 40?
Below an eGFR of 45, cap metformin at 1,000 mg daily and recheck renal function within three months.pubmedL2
Hold it before iodinated contrast when eGFR is under 60.nice
Evidence that knows the patient
Ask with the chart open and Vero answers for this patient — their labs, their medications, their kidneys.
Chart in hand. Answers account for the problem list, medications, and latest labs on file.
Mid-visit, mid-sentence. Ask while Vero is scribing — the answer arrives without breaking the conversation.
R. Dhaliwal
67 y · she/her
Problem list
HFrEF, hypertension, CKD 3b
Medications
Lisinopril 20 mg, carvedilol 12.5 mg
Latest labs
eGFR 48 · K+ 4.9 mmol/L
Safe to add spironolactone here?
Caution — her potassium is already 4.9 with an eGFR of 48, both near the thresholds where trials saw hyperkalemia.pubmedL1
If you start low, guidelines advise rechecking potassium within a week.nice
Your sources, cited too
Add the documents your practice actually runs on, and Vero searches them alongside the literature.
Curate collections. Society guidelines, clinic protocols, formularies — organized the way you think.
Cited by name. Answers drawn from your library name the exact document they came from.
Library
Starting dose per our hypertension protocol?
Your clinic protocol starts amlodipine at 2.5 mg for patients over 65, titrating at two-week intervals (Source: 2026 Clinic Hypertension Protocol).
Trusted by clinicians who check the references
Practice with the evidence beside you.
Vero Evidence comes with every Vero plan — on the web, iOS, and Android.
No credit card required
Cancel anytime